TrialThe Journal of clinical endocrinology and metabolism2011

Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.

Samantha Kimball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.